789 results on '"Bouscary, Didier"'
Search Results
2. Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutation
3. FOXP1 regulates oxidative stress, SIRT1 expression, and resistance to chemotherapies in acute myeloid leukemia cells
4. Accuracy and safety of 101 consecutives neurosurgical procedures for newly diagnosed central nervous system lymphomas: a single-institution experience
5. Supplementary Figure 7 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
6. Supplementary Figure 1 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
7. Supplementary Figure 8 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
8. Supplementary Figure 2 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
9. Supplementary Table 2 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
10. Supplementary Table 1 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
11. Movie Sup 1.TAS cells have greater migratory capacity than untreated T cells in viable Capan-2 tumors explant. from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
12. Supplementary Figure 3 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
13. Data from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
14. Supplementary Figure 6 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
15. Supplementary Figure 4 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
16. RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia
17. Pediatric Plasma Cell Neoplasms: A Population-Based Study
18. A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome.
19. Antimicrobial stewardship in high-risk febrile neutropenia patients
20. Hematopoietic differentiation is characterized by a transient peak of entropy at a single-cell level
21. Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cells
22. Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patients
23. Evolution of radiotherapy techniques for mediastinal Hodgkin lymphoma: a single-center experience
24. Cancer during pregnancy: Factors associated with termination of pregnancy and perinatal outcomes
25. Mastocytosis onset in a patient with treated hairy cell leukemia: Just a coincidence?
26. Solitary Plasmacytoma Treated by Lenalidomide-Dexamethasone in Combination with Radiation Therapy: Clinical Outcomes
27. How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
28. Proton Therapy Reduces the Effective Dose to Immune Cells in Mediastinal Hodgkin Lymphoma Patients
29. Successful nelarabine and venetoclax treatment of a relapsed/refractory mediastinal myeloid sarcoma with clonal TCR rearrangement
30. FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
31. Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM)
32. S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
33. Data from C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in FLT3-Mutant Leukemia
34. Supplementary Information v.2 from C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in FLT3-Mutant Leukemia
35. Supplementary Figures S1-S22 from C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in FLT3-Mutant Leukemia
36. Clinico‐biological features, treatment and prognosis of primary myeloid sarcoma: A French retrospective multi‐centric observational study
37. Supplementary Table S15 from C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in FLT3-Mutant Leukemia
38. Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis
39. Toxicité rénale du méthotrexate à haute dose
40. Antileukemic activity of the VPS34-IN1 inhibitor in acute myeloid leukemia
41. Immunogenicity and persistence of the 13-valent Pneumococcal Conjugate Vaccine (PCV13) in patients with untreated Smoldering Multiple Myeloma (SMM): A pilot study
42. Management of Gastro-Intestinal Toxicity of the Pi3 Kinase Inhibitor: Optimizing Future Dosing Strategies
43. C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis inFLT3-Mutant Leukemia
44. Architectural and functional heterogeneity of hematopoietic stem/progenitor cells in non-del(5q) myelodysplastic syndromes
45. A colonic mass revealing a disseminated crystal storing histiocytosis secondary to indolent multiple myeloma: a case report with literature review
46. Partial response in hairy cell leukemia with vemurafenib despite early discontinuation due to agranulocytosis
47. Supplementary Figure Legend, Table 1 from Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia
48. Supplementary Figures 1 - 4 from Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia
49. Subcutaneous azacitidine maintenance in transplantineligible patients with acute myeloid leukemia: a single-center retrospective study
50. In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.